← CRS Congressional Research Service reports

Xylazine: Considerations for Federal Control

IN · Insight · 2023-08-01 · IN12086

Report

CRS ID
IN12086
Series
Insight
Publication date
2023-08-01

Documents

PDF
https://www.everycrsreport.com/files/2023-08-01_IN12086_6e0761945813828db72651b5d8f45e6a7bf7e284.pdf
HTML
https://www.everycrsreport.com/files/2023-08-01_IN12086_6e0761945813828db72651b5d8f45e6a7bf7e284.html
Source
EveryCRSReport.com
Machine
JSON-LD · Markdown